Carboplatin-based chemotherapy in patients with gynecological malignancies on long-term hemodialysis.
We report on three cases of long-term dialysis patients with gynecological malignancies who were successfully treated with chemotherapy. Two epithelial ovarian carcinoma patients were treated with a single agent, carboplatin (100-200 mg/m2). One recurrent endometrial carcinoma patient was treated with carboplatin (200 mg/m2) and paclitaxel (135 mg/m2). Hemodialysis was started 2 h after the carboplatin infusion and lasted 4 h in all three cases. All patients tolerated these therapies without significant myelosuppression or severe side-effects. Our findings suggest these regimens are feasible, and the combination of paclitaxel and carboplatin is effective chemotherapy when administered to long-term hemodialysis patients with recurrent endometrial carcinoma.
Niikura
Hitoshi
H
Department of Obstetrics and Gynecology, Tohoku University School of Medicine, Sendai, Japan.
Koizumi
Toshimitsu
T
Ito
Kiyoshi
K
Okamura
Kunihiro
K
Yaegashi
Nobuo
N
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016190:Carboplatin / Q000008:administration & dosage / Q000627:therapeutic use*; D016889:Endometrial Neoplasms / Q000150:complications / Q000188:drug therapy; D005260:Female; D005833:Genital Neoplasms, Female / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D010051:Ovarian Neoplasms / Q000150:complications / Q000188:drug therapy; D017239:Paclitaxel / Q000008:administration & dosage; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000150:complications / Q000628:therapy*; D013997:Time Factors
D000970:Antineoplastic Agents; D016190:Carboplatin; D017239:Paclitaxel